Skip to main content

Among the challenges are moments of joy.

The federal government is committed to making every day better for people with dementia, their caregivers, and their families.

 

Find out how we’re taking action.

Why Participate in a Clinical Trial?

When you volunteer for a clinical trial, you help bring us closer to Alzheimer’s treatment and prevention discoveries.

News & Events

older adult with dementia, wearing a mask and waiting in a doctor's office
Dementia increases the risk and severity of COVID-19, study finds
A large-scale study shows that people with dementia, especially Black Americans with dementia, have a significantly higher risk of getting COVID-19.
Nurse caring for an older woman in a nursing home
Cognitive impairment among factors linked to elevated death rates in nursing home residents with COVID-19
Study links cognitive impairment as well as age, gender, chronic medical conditions, and physical limitations to a heightened risk of death among nursing home residents with COVID-19.
Graphic showing the genetic overlap between Lewy body dementia with Alzheimer’s and Parkinson’s diseases. Words “Genetic Risk" at top, underneath, blue icons show people who are labeled “Lewy body dementia." Dotted grey lines drawn from the top to connect grey icons of people below. Under each icon is an arc to represent risk of each group for Alzheimer's disease and Parkinson's diseases.
Genetic study of Lewy body dementia supports ties to Alzheimer’s and Parkinson’s diseases

In a study led by National Institutes of Health (NIH) researchers, scientists found that five genes may play a critical role in determining whether a person will suffer from Lewy body dementia, a devastating disorder that riddles the brain with clumps of abnormal protein deposits called Lewy bodies.